Cuprina Holdings (Cayman) LTD
About Cuprina Holdings (Cayman) LTD
Cuprina Holdings (Cayman) Ltd is a biomedical and biotechnology company that is dedicated to the development and commercialization of products for the management of chronic wounds, as well as operating in the health and beauty sector. It manufactured and distributed a line of medical grade sterile blowfly larvae bio-dressing products marketed under the MEDIFLY brand name, or the MEDIFLY products. The MEDIFLY products are used as a biological debridement tool for chronic wounds, in a procedure known as Maggot Debridement Therapy, or MDT, which is an effective alternative to surgical debridement.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $38.8K
- Net income
- -$3.6M
- Total assets
- $6.6M
- Market cap
- $6.5M
Source: SEC EDGAR · updated Jun 7, 2026
- Market cap
- $6.5M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Apr 10, 2025
Market data by Polygon.io · prices are 15-minute delayed
No reviews yet. Be the first to review Cuprina Holdings (Cayman) LTD.
